{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:16:28Z","timestamp":1790234188600,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802709"],"award-info":[{"award-number":["81802709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010009","name":"Heilongjiang Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2017GSF218064"],"award-info":[{"award-number":["2017GSF218064"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["2017JC010"],"award-info":[{"award-number":["2017JC010"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.intimp.2019.105921","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T11:49:30Z","timestamp":1570448970000},"page":"105921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma"],"prefix":"10.1016","volume":"76","author":[{"given":"Miao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.intimp.2019.105921_b0005","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1158\/0008-5472.CAN-11-0950","article-title":"Human tumor cells killed by anthracyclines induce a tumor-specific immune response","volume":"71","author":"Fucikova","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2019.105921_b0010","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"29","author":"Tesniere","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2019.105921_b0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7150\/ijbs.12852","article-title":"Photodynamic-therapy activates immune response by disrupting immunity homeostasis of tumor cells, which generates vaccine for cancer therapy","volume":"12","author":"Zheng","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2019.105921_b0020","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41418-017-0044-9","article-title":"eIF2alpha phosphorylation is pathognomonic for immunogenic cell death","volume":"25","author":"Bezu","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2019.105921_b0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcancer.2015.02.004","article-title":"eIF2alpha phosphorylation as a biomarker of immunogenic cell death","volume":"33","author":"Kepp","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2019.105921_b0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-065X.2007.00567.x","article-title":"Ecto-calreticulin in immunogenic chemotherapy","volume":"220","author":"Obeid","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2019.105921_b0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2006","journal-title":"Nat. Med."},{"issue":"6102","key":"10.1016\/j.intimp.2019.105921_b0040","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1126\/science.1224922","article-title":"An immunosurveillance mechanism controls cancer cell ploidy","volume":"337","author":"Senovilla","year":"2012","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.intimp.2019.105921_b0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/cmi.2013.59","article-title":"TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells","volume":"11","author":"Fang","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105921_b0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/imr.12574","article-title":"Cell death and immunity in cancer: from danger signals to mimicry of pathogen defense responses","volume":"280","author":"Garg","year":"2017","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2019.105921_b0055","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.955691","article-title":"Consensus guidelines for the detection of immunogenic cell death","volume":"3","author":"Kepp","year":"2014","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.intimp.2019.105921_b0060","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/emboj.2009.1","article-title":"Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death","volume":"28","author":"Panaretakis","year":"2009","journal-title":"Embo J."},{"key":"10.1016\/j.intimp.2019.105921_b0065","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/cdd.2008.67","article-title":"The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death","volume":"15","author":"Panaretakis","year":"2008","journal-title":"Cell Death Diff."},{"issue":"6","key":"10.1016\/j.intimp.2019.105921_b0070","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2019.105921_b0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.canlet.2018.01.051","article-title":"Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinoma","volume":"419","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.intimp.2019.105921_b0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1158\/1078-0432.CCR-16-0914","article-title":"Bromodomain and extraterminal protein inhibitor JQ1 suppresses thyroid tumor growth in a mouse model","volume":"23","author":"Zhu","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2019.105921_b0085","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jcmm.13059","article-title":"The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo","volume":"21","author":"Jostes","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"7","key":"10.1016\/j.intimp.2019.105921_b0090","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/onc.2015.126","article-title":"The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models","volume":"35","author":"Garcia","year":"2016","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.intimp.2019.105921_b0095","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-16-1020","article-title":"Synergistic immunostimulatory effects and therapeutic benefit of combined histone deacetylase and bromodomain inhibition in non-small cell lung cancer","volume":"7","author":"Adeegbe","year":"2017","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.intimp.2019.105921_b0100","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1158\/1078-0432.CCR-15-1666","article-title":"The Bromodomain inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat synergistically reduce N-Myc expression and induce anticancer effects","volume":"22","author":"Shahbazi","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"17\u201318","key":"10.1016\/j.intimp.2019.105921_b0105","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gad.315648.118","article-title":"Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4\/6is","volume":"32","author":"Liao","year":"2018","journal-title":"Genes Dev."},{"issue":"4\u20135","key":"10.1016\/j.intimp.2019.105921_b0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","article-title":"Global epidemiology of oral and oropharyngeal cancer","volume":"45","author":"Warnakulasuriya","year":"2009","journal-title":"Oral. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2019.105921_b0115","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1634\/theoncologist.2009-0289","article-title":"Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis","volume":"15","author":"Pulte","year":"2010","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.intimp.2019.105921_b0120","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4143\/crt.2016.317","article-title":"Clinicopathologic characteristics and prognosis of tongue squamous cell carcinoma in patients with and without a history of radiation for Nasopharyngeal Carcinoma: a matched case-control study","volume":"49","author":"Zhang","year":"2017","journal-title":"Cancer Res. Treat"},{"issue":"4","key":"10.1016\/j.intimp.2019.105921_b0125","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3892\/or.2016.5037","article-title":"JQ1, a small molecule inhibitor of BRD4, suppresses cell growth and invasion in oral squamous cell carcinoma","volume":"36","author":"Wang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2019.105921_b0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tibs.2015.06.002","article-title":"Beating the odds: BETs in disease","volume":"40","author":"Wang","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2019.105921_b0135","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET Bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore Jake","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2019.105921_b0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.mex.2018.05.011","article-title":"Optimization of phenol-chloroform RNA extraction","volume":"5","author":"Toni","year":"2018","journal-title":"MethodsX"},{"issue":"3","key":"10.1016\/j.intimp.2019.105921_b0145","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4049\/jimmunol.1800188","article-title":"Ligation of the CD44 Glycoform HCELL on culture-expanded human monocyte-derived dendritic cells programs transendothelial migration","volume":"201","author":"Videira","year":"2018","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2019.105921_b0150","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.4049\/jimmunol.1401635","article-title":"Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation","volume":"194","author":"Toniolo","year":"2015","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2019.105921_b0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/14653240310003053","article-title":"Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection","volume":"5","author":"Felzmann","year":"2003","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.intimp.2019.105921_b0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/14653240310003017","article-title":"A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCs","volume":"5","author":"Bracho","year":"2003","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.intimp.2019.105921_b0165","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41467-017-01651-9","article-title":"Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression","volume":"8","author":"Lu","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2019.105921_b0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2019.105921_b0175","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2019.105921_b0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0962-8924(01)01926-2","article-title":"The ins and outs of calreticulin: from the ER lumen to the extracellular space","volume":"11","author":"Johnson","year":"2001","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105921_b0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2019.105921_b0190","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4\u2013dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2019.105921_b0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/cdd.2013.75","article-title":"Molecular mechanisms of ATP secretion during immunogenic cell death","volume":"21","author":"Martins","year":"2014","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.intimp.2019.105921_b0200","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.4161\/auto.25873","article-title":"Autophagy-dependent ATP release from dying cells via lysosomal exocytosis","volume":"9","author":"Wang","year":"2013","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.intimp.2019.105921_b0205","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/emboj.2011.497","article-title":"A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death","volume":"31","author":"Garg","year":"2012","journal-title":"Embo J."},{"issue":"1","key":"10.1016\/j.intimp.2019.105921_b0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/cdd.2013.84","article-title":"Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments","volume":"21","author":"Inoue","year":"2014","journal-title":"Cell Death Differ."},{"issue":"12","key":"10.1016\/j.intimp.2019.105921_b0215","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2019.105921_b0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12967-016-0848-2","article-title":"Unexpected impairment of TNF-\u03b1-induced maturation of human dendritic cells in vitro by IL-4","volume":"14","author":"Chabot","year":"2016","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2019.105921_b0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2019.105921_b0230","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1192739","article-title":"Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death","volume":"5","author":"Di Blasio","year":"2016","journal-title":"Oncoimmunology"},{"issue":"49","key":"10.1016\/j.intimp.2019.105921_b0235","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1708383114","article-title":"Atypical activation of dendritic cells by Plasmodium falciparum","volume":"114","author":"G\u00f6tz","year":"2017","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.intimp.2019.105921_b0240","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1431089","article-title":"eIF2alpha phosphorylation: a hallmark of immunogenic cell death","volume":"7","author":"Bezu","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2019.105921_b0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2015.03.010","article-title":"The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond","volume":"33","author":"van Vliet","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.intimp.2019.105921_b0250","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1398874","article-title":"Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment","volume":"7","author":"Riganti","year":"2017","journal-title":"Oncoimmunology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919314079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919314079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:42:16Z","timestamp":1786376536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919314079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":50,"alternative-id":["S1567576919314079"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105921","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105921"}}